The current stock price of HSIC is 79.98 USD. In the past month the price increased by 4.4%. In the past year, price increased by 9.23%.
ChartMill assigns a technical rating of 8 / 10 to HSIC. When comparing the yearly performance of all stocks, HSIC is one of the better performing stocks in the market, outperforming 78.94% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to HSIC. HSIC has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months HSIC reported a non-GAAP Earnings per Share(EPS) of 4.82. The EPS increased by 14.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.02% | ||
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| Debt/Equity | 0.91 |
23 analysts have analysed HSIC and the average price target is 79.3 USD. This implies a price decrease of -0.85% is expected in the next year compared to the current price of 79.98.
For the next year, analysts expect an EPS growth of 5.85% and a revenue growth 2.46% for HSIC
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 23.17 | 103.74B | ||
| COR | CENCORA INC | 22.19 | 68.84B | ||
| CAH | CARDINAL HEALTH INC | 23.84 | 50.48B | ||
| AHCO | ADAPTHEALTH CORP | 33.16 | 1.44B | ||
| ACH | ACCENDRA HEALTH INC | 1.95 | 194.92M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 36.40M |
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 25,000 full-time employees. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.
HENRY SCHEIN INC
135 Duryea Rd
Melville NEW YORK 11747 US
CEO: Stanley M. Bergman
Employees: 25000
Phone: 16318435500
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 25,000 full-time employees. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.
The current stock price of HSIC is 79.98 USD. The price increased by 2.43% in the last trading session.
HSIC does not pay a dividend.
HSIC has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
HENRY SCHEIN INC (HSIC) operates in the Health Care sector and the Health Care Providers & Services industry.
The PE ratio for HENRY SCHEIN INC (HSIC) is 16.59. This is based on the reported non-GAAP earnings per share of 4.82 and the current share price of 79.98 USD.
The outstanding short interest for HENRY SCHEIN INC (HSIC) is 5.73% of its float.